Anita Mamtani, MD FACS

Memorial Sloan Kettering Cancer Center is a worldwide leader in the treatment of cancer. Patients may be admitted to Memorial Hospital at 1275 York Avenue in New York City for treatment or symptom management, based on their cancer diagnosis or a related illness...

Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

Memorial Sloan Kettering hematologic oncologist Esperanza Papadopoulos specializes in using blood and marrow transplantation to treat leukemia, lymphoma, and other blood cancers. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week...